Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HYPERTHERMIA
Volume 39, Issue 1, Pages 706-712
Publisher
Informa UK Limited
Online
2022-04-29
DOI
10.1080/02656736.2022.2066728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peritoneal mesothelioma
- (2020) Alissa Greenbaum et al. Translational Lung Cancer Research
- Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without Hyperthermic IntraPEritoneal Chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative Management and Special Considerations
- (2020) Martin Hübner et al. EJSO
- Osteopontin, GLUT1 and Ki67 expression in malignant peritoneal mesothelioma: Prognostic implications
- (2020) L Ying‐ying et al. INTERNAL MEDICINE JOURNAL
- Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations — Part I: Preoperative and intraoperative management
- (2020) Martin Hübner et al. EJSO
- Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience
- (2020) Fabio Carboni et al. EJSO
- Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases
- (2020) David B. Chapel et al. MODERN PATHOLOGY
- Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery + intra-peritoneal chemotherapy
- (2019) Bhavneet Singh et al. AMERICAN JOURNAL OF SURGERY
- Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
- (2019) P. Cascales Campos et al. Clinical & Translational Oncology
- Peritoneal mesothelioma in Sweden: A population‐based study
- (2019) Peter H. Cashin et al. Cancer Medicine
- Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival
- (2018) Vivek Verma et al. ANNALS OF SURGICAL ONCOLOGY
- Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival
- (2018) Syeda Nadia Shah Gilani et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking
- (2018) Samer A. Naffouje et al. MEDICAL ONCOLOGY
- Peritoneal Metastases from Malignant Mesothelioma
- (2018) Claire Yue Li et al. Surgical Oncology Clinics of North America
- Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database
- (2016) V. Kepenekian et al. EUROPEAN JOURNAL OF CANCER
- Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
- (2016) Yan Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray
- (2015) Marcello Deraco et al. ANNALS OF SURGICAL ONCOLOGY
- The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- (2015) Shigeki Kusamura et al. ANNALS OF SURGICAL ONCOLOGY
- Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature
- (2015) Konstantinos Stamou et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis
- (2014) Joseph H. Helm et al. ANNALS OF SURGICAL ONCOLOGY
- Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent or Progressive Diffuse Malignant Peritoneal Mesothelioma: Clinicopathologic Characteristics and Survival Outcome
- (2014) Chukwuemeka Ihemelandu et al. ANNALS OF SURGICAL ONCOLOGY
- Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies
- (2014) Patricio M. Polanco et al. ANNALS OF SURGICAL ONCOLOGY
- Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis
- (2013) Deepa Magge et al. ANNALS OF SURGICAL ONCOLOGY
- Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study
- (2013) J. Hommell-Fontaine et al. ANNALS OF SURGICAL ONCOLOGY
- Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)
- (2013) Dario Baratti et al. EUROPEAN JOURNAL OF CANCER
- Diffuse malignant peritoneal mesothelioma – An update on treatment
- (2011) Peyman Mirarabshahii et al. CANCER TREATMENT REVIEWS
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
- (2009) Tristan D. Yan et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started